Onward Therapeutics SA (Onward Therapeutics), a global biotechnology company focused on developing innovative immunotherapies for cancer treatment, today announced that the phase 1 clinical trial of OT-A201 (Study No. A20101), a first-in-class bispecific antibody targeting two immune checkpoints is in progress.
(MENAFN - PR Newswire) EPALINGES,Switzerland and PARIS, Jan. 24, 2024 /PRNewswire/ Onward Therapeutics SA (Onward Therapeutics), a global biotechnology company focused on developing innovative . .
Form 8-K ADC Therapeutics SA For: Jan 04 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) and ADC Therapeutics (NYSE:ADCT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends. Profitability This table compares Acrivon Therapeutics and […]